Navigation Links
Outlook with Ben Kingsley Spotlighting Glaucoma in Upcoming Report
Date:7/17/2013

Hollywood, CA (PRWEB) July 17, 2013

Affecting more than 2.2 million Americans, glaucoma is one of the leading causes of blindness. However, only half of the people with glaucoma even know they have it. Glaucoma is a group of conditions that causes damage in the eye’s optic nerve and is often associated with increased pressure inside the eye. However, the condition develops very slowly and often times goes unnoticed until it reaches an advanced stage.

Sometimes described as the “silent thief of the night”, there are virtually no noticeable symptoms or pain associated with the most common form of glaucoma. In many cases, individuals do not notice the condition until significant vision loss has occurred. Early detection, through regular check ups and testing, is crucial and subsequent treatment will minimize nerve damage and limit vision loss leading to blindness.

Outlook with Ben Kingsley will shine a light on glaucoma and educate the viewers on the importance of early detection and treatment. The program will also feature medical professionals treating patients with conditions ranging from minimal vision loss to blindness.

Outlook Ben Kingsley is distributed to public television stations throughout the United States and is not distributed through PBS. Please visit the official website at outlooktelevision.com for more information.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10938584.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Outlook Ben Kingsley Educating About Head and Neck Cancer
2. Outlook with Ben Kingsley Exploring Role of Nanotechnology in Medicine for Upcoming Report
3. Outlook with Ben Kingsley Producing Program on Addiction Treatment
4. Outlook with Ben Kingsley Examines International Access to Medical Care in Upcoming Report
5. Voices Against Brain Cancer Commends Brain Cancer Survivor For His Positive Outlook
6. Delays in diagnosis worsen outlook for minority, uninsured pediatric retinoblastoma patients
7. Economy May Have Lasting Effect on Young Peoples Outlook
8. Fathom Wraps 2012 with Bang; Sees Strong Growth Outlook for Year Ahead
9. 2013 economic outlook for global chemical industry
10. Jan. 17 Atlantic Information Services Webinar Offers Insights on Wall Street’s 2013 Outlook for Health Plans
11. Healthy outlook leads to a healthy lifestyle: study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/24/2017)... ... ... Millions of families and businesses worldwide depend on high quality water from ... water. However, well water can also become contaminated with bacteria and odors from flood ... The EPA does not regulate private drinking water wells. Many states and towns do ...
(Date:9/24/2017)... ... ... boy was walking home and feeling down about himself. He didn’t think he was good ... he can do whatever he wants to do if he puts his mind to it. ... God created him with special talents and gifts. We see his internal dialogue change. He ...
(Date:9/24/2017)... ... ... The Other Sheep”: the ceremonial laws of Moses and the Holy Law of God reexamined. ... author, Maurice Caines. Maurice Caines resides in the sunny isle of Florida, but he ... Adventist Church for many years. He was previously a member of the Anglican Church ...
(Date:9/23/2017)... San Francisco, CA (PRWEB) , ... September 23, 2017 , ... ... Bay Area, is proud to announce a new blog post focused on the ARTAS® ... loss, they understandably hope to turn to the latest, most technologically sophisticated methods of ...
(Date:9/22/2017)... Albert Lea, MN (PRWEB) , ... September 22, 2017 , ... ... and video) at its rally to interview citizens on why they are rallying against ... stories and commitment to this effort against Dr. Noseworthy’s (CEO) decision to close the ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
(Date:9/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... will be participating in the Morgan Stanley 15 th ... hotel in New York.  Zimmer Biomet will present on ... A live webcast of the presentation can ... http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
Breaking Medicine Technology: